亚胺_(154),化学名为乙二胺四乙酰亚胺或双二氧哌嗪乙烷,简称ICRF_(154),是一种新型抗肿瘤药物。对多种移植性肿瘤有显著的抑制作用。临床观察证明,对淋巴肉瘤、白血病、恶性网状细胞增多症、肺癌、胃癌、各种软组织肉瘤及何杰金氏病等,都有一定的治疗和缓解作用。一九七三年底,南京军区总医院首次用于银屑病(牛皮癣)的治疗,取得了较好的治疗效果。后经北京、 Imide _ (154), the chemical name of ethylenediamine tetraacetyl imide or bis-dioxopiperazine ethane, referred to as ICRF_ (154), is a new type of anti-tumor drugs. A variety of transplant tumors have a significant inhibitory effect. Clinical observations show that on lymphosarcoma, leukemia, reticulocytosis, lung cancer, gastric cancer, various soft tissue sarcoma and Hodgkin’s disease, etc., have a certain degree of treatment and remission. The end of 1973, Nanjing Military Region General Hospital for the first time for the treatment of psoriasis (psoriasis), and achieved good therapeutic effect. After Beijing,